Regulation of retinal blood flow in health and disease

被引:466
作者
Pournaras, Constantin J. [1 ]
Rungger-Braendle, Elisabeth [2 ]
Riva, Charles E. [3 ]
Hardarson, H. [4 ]
Stefansson, Einar [4 ]
机构
[1] Univ Hosp Geneva, Dept Ophthalmol, Vitreo Retina Unit, CH-1211 Geneva 14, Switzerland
[2] Univ Hosp Geneva, Dept Ophthalmol, Cell Biol Lab, CH-1211 Geneva 14, Switzerland
[3] Univ Bologna, Dept Ophthalmol, I-40126 Bologna, Italy
[4] Univ Iceland, Dept Ophthalmol, Reykjavik, Iceland
关键词
D O I
10.1016/j.preteyeres.2008.02.002
中图分类号
R77 [眼科学];
学科分类号
100212 ;
摘要
Optimal retinal neuronal cell function requires an appropriate, tightly regulated environment, provided by cellular barriers, which separate functional compartments, maintain their homeostasis, and control metabolic substrate transport. Correctly regulated hemodynamics and delivery of oxygen and metabolic substrates, as well as intact blood-retinal barriers are necessary requirements for the maintenance of retinal structure and function. Retinal blood flow is autoregulated by the interaction of myogenic and metabolic mechanisms through the release of vasoactive substances by the vascular endothelium and retinal tissue surrounding the arteriolar wall. Autoregulation is achieved by adaptation of the vascular tone of the resistance vessels (arterioles, capillaries) to changes in the perfusion pressure or metabolic needs of the tissue. This adaptation occurs through the interaction of multiple mechanisms affecting the arteriolar smooth muscle cells and capillary pericytes. Mechanical stretch and increases in arteriolar transmural pressure induce the endothelial cells to release contracting factors affecting the tone of arteriolar smooth muscle cells and pericytes. Close interaction between nitric oxide (NO), lactate, arachidonic acid metabolites, released by the neuronal and glial cells during neural activity and energy-generating reactions of the retina strive to optimize blood flow according to the metabolic needs of the tissue. NO, which plays a central role in neurovascular coupling, may exert its effect, by modulating glial cell function involved in such vasomotor responses. During the evolution of ischemic microangiopathies, impairment of structure and function of the retinal neural tissue and endothelium affect the interaction of these metabolic pathways, leading to a disturbed blood flow regulation. The resulting ischemia, tissue hypoxia and alterations in the blood barrier trigger the formation of macular edema and neovascularization. Hypoxia-related VEGF expression correlates with the formation of neovessels. The relief from hypoxia results in arteriolar constriction, decreases the hydrostatic pressure in the capillaries and venules, and relieves endothelial stretching. The reestablished oxygenation of the inner retina downregulates VEGF expression and thus inhibits neovascularization and macular edema. Correct control of the multiple pathways, such as retinal blood flow, tissue oxygenation and metabolic substrate support, aiming at restoring retinal cell metabolic interactions, may be effective in preventing damage occurring during the evolution of ischemic microangiopathies. (C) 2008 Elsevier Ltd. All rights reserved.
引用
收藏
页码:284 / 330
页数:47
相关论文
共 585 条
[1]   Characterization of retinal leukostasis and hemodynamics in insulin resistance and diabetes - Role of oxidants and protein kinase-C activation [J].
Abiko, T ;
Abiko, A ;
Clermont, AC ;
Shoelson, B ;
Horio, N ;
Takahashi, J ;
Adamis, AP ;
King, GL ;
Bursell, SE .
DIABETES, 2003, 52 (03) :829-837
[2]   Mechanism of the pathogenesis of glutamate neurotoxicity in retinal ischemia [J].
Adachi, K ;
Kashii, S ;
Masai, H ;
Ueda, M ;
Morizane, C ;
Kaneda, K ;
Kume, T ;
Akaike, A ;
Honda, Y .
GRAEFES ARCHIVE FOR CLINICAL AND EXPERIMENTAL OPHTHALMOLOGY, 1998, 236 (10) :766-774
[3]   INCREASED VASCULAR ENDOTHELIAL GROWTH-FACTOR LEVELS IN THE VITREOUS OF EYES WITH PROLIFERATIVE DIABETIC-RETINOPATHY [J].
ADAMIS, AP ;
MILLER, JW ;
BERNAL, MT ;
DAMICO, DJ ;
FOLKMAN, J ;
YEO, TK ;
YEO, KT .
AMERICAN JOURNAL OF OPHTHALMOLOGY, 1994, 118 (04) :445-450
[4]  
AHMED J, 1993, INVEST OPHTH VIS SCI, V34, P516
[5]   VASCULAR ENDOTHELIAL GROWTH-FACTOR IN OCULAR FLUID OF PATIENTS WITH DIABETIC-RETINOPATHY AND OTHER RETINAL DISORDERS [J].
AIELLO, LP ;
AVERY, RL ;
ARRIGG, PG ;
KEYT, BA ;
JAMPEL, HD ;
SHAH, ST ;
PASQUALE, LR ;
THIEME, H ;
IWAMOTO, MA ;
PARK, JE ;
NGUYEN, HV ;
AIELLO, LM ;
FERRARA, N ;
KING, GL .
NEW ENGLAND JOURNAL OF MEDICINE, 1994, 331 (22) :1480-1487
[6]   Tight junctions: Molecular architecture and function [J].
Aijaz, S ;
Balda, MS ;
Matter, K .
INTERNATIONAL REVIEW OF CYTOLOGY - A SURVEY OF CELL BIOLOGY, VOL 248, 2006, 248 :261-298
[7]  
ALDER VA, 1990, INVEST OPHTH VIS SCI, V31, P1029
[8]   THE EFFECT OF THE RETINAL CIRCULATION ON VITREAL OXYGEN-TENSION [J].
ALDER, VA ;
CRINGLE, SJ .
CURRENT EYE RESEARCH, 1985, 4 (02) :121-129
[9]   CHANGES IN VITREAL OXYGEN-TENSION DISTRIBUTION IN THE STREPTOZOTOCIN DIABETIC RAT [J].
ALDER, VA ;
YU, DY ;
CRINGLE, SJ ;
SU, EN .
DIABETOLOGIA, 1991, 34 (07) :469-476
[10]  
ALDER VA, 1983, INVEST OPHTH VIS SCI, V24, P30